Multicenter Study in Postmenopausal Women With Osteoporosis, ALVOBOND

Clinical trial NCT05395091 · COMPLETED

Trial details

NCT number: NCT05395091
Sponsor: Alvotech Swiss AG
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Osteoporosis, Postmenopausal

Start date: 2022-08-23
Primary completion: 2024-05-07
Enrollment: 532

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.